Mangoceuticals (MGRX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.32, -2.13% vs the prior close of $0.33.
- Volume 663.70K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MGRX dips 2.1% to $0.32, a 1-month low, 7 down days in a row. Closed at $0.32, -2.13% vs the prior close of $0.33. Day range $0.32–$0.36, opened at $0.34.
MGRX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MGRX dips 2.1% to $0.32, a 1-month low, 7 down days in a row
- Closed at $0.32, -2.13% vs the prior close of $0.33. Day range $0.32–$0.36, opened at $0.34.
- Volume was 663.70K shares, 0.2x its 50-day average of 4.06M — lighter than usual.
- Price is -26.1% vs its 50-day average ($0.43) and -26.5% vs its 200-day average ($0.44).
- 52-week range $0.16–$2.75; today's close sits at 6% of that range, 88.3% below the 52-week high.
- That makes 7 straight losses.
Oct 14, 2026 — MGRX slides 11.8% to $0.33, a 1-month low, 6 down days in a row
- Closed at $0.33, -11.83% vs the prior close of $0.37. Day range $0.31–$0.38, opened at $0.38.
- Volume was 676.30K shares, 0.2x its 50-day average of 4.12M — lighter than usual.
- Price is -24.9% vs its 50-day average ($0.44) and -25.2% vs its 200-day average ($0.44).
- 52-week range $0.16–$2.75; today's close sits at 6% of that range, 88.1% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — MGRX dips 2.9% to $0.37, a 1-month low, 5 down days in a row
- Closed at $0.37, -2.87% vs the prior close of $0.38. Day range $0.37–$0.39, opened at $0.38.
- Volume was 299.20K shares, 0.1x its 50-day average of 4.42M — lighter than usual.
- Price is -15.3% vs its 50-day average ($0.44) and -15.6% vs its 200-day average ($0.44).
- 52-week range $0.16–$2.75; today's close sits at 8% of that range, 86.5% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — MGRX slides 9.2% to $0.38, a 1-month low, 4 down days in a row
- Closed at $0.38, -9.24% vs the prior close of $0.42. Day range $0.38–$0.42, opened at $0.42.
- Volume was 449.30K shares, 0.0x its 50-day average of 14.65M — lighter than usual.
- Price is -13.4% vs its 50-day average ($0.44) and -13.5% vs its 200-day average ($0.44).
- 52-week range $0.16–$2.75; today's close sits at 9% of that range, 86.1% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — MGRX dips 2.3% to $0.42, 3 down days in a row
- Closed at $0.42, -2.31% vs the prior close of $0.43. Day range $0.41–$0.44, opened at $0.44.
- Volume was 431.70K shares, 0.0x its 50-day average of 16.25M — lighter than usual.
- Price is -5.4% vs its 50-day average ($0.45) and -5.1% vs its 200-day average ($0.44).
- 52-week range $0.16–$2.75; today's close sits at 10% of that range, 84.7% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K, 424B5.
Oct 8, 2026 — MGRX dips 2.7% to $0.43
- Closed at $0.43, -2.70% vs the prior close of $0.44. Day range $0.42–$0.46, opened at $0.44.
- Volume was 583.80K shares, 0.0x its 50-day average of 16.25M — lighter than usual.
- Price is -2.6% vs its 50-day average ($0.44) and -3.2% vs its 200-day average ($0.45).
- 52-week range $0.16–$2.75; today's close sits at 10% of that range, 84.3% below the 52-week high.
Oct 7, 2026 — MGRX dips 1.3% to $0.44
- Closed at $0.44, -1.33% vs the prior close of $0.45. Day range $0.43–$0.48, opened at $0.43.
- Volume was 646.10K shares, 0.0x its 50-day average of 16.25M — lighter than usual.
- Price is -0.4% vs its 50-day average ($0.45) and -0.8% vs its 200-day average ($0.45).
- 52-week range $0.16–$2.75; today's close sits at 11% of that range, 83.9% below the 52-week high.
Oct 6, 2026 — MGRX jumps 7.7% to $0.45
- Closed at $0.45, +7.66% vs the prior close of $0.42. Day range $0.41–$0.46, opened at $0.42.
- Volume was 831.70K shares, 0.1x its 50-day average of 16.24M — lighter than usual.
- Price is +0.4% vs its 50-day average ($0.45) and -0.5% vs its 200-day average ($0.45).
- 52-week range $0.16–$2.75; today's close sits at 11% of that range, 83.6% below the 52-week high.
Oct 5, 2026 — MGRX slides 4.3% to $0.42
- Closed at $0.42, -4.35% vs the prior close of $0.44. Day range $0.41–$0.44, opened at $0.43.
- Volume was 576.70K shares, 0.0x its 50-day average of 16.24M — lighter than usual.
- Price is -7.1% vs its 50-day average ($0.45) and -8.3% vs its 200-day average ($0.46).
- 52-week range $0.16–$2.75; today's close sits at 10% of that range, 84.8% below the 52-week high.
Oct 2, 2026 — MGRX slides 9.1% to $0.44
- Closed at $0.44, -9.15% vs the prior close of $0.48. Day range $0.43–$0.44, opened at $0.43.
- Volume was 876.20K shares, 0.1x its 50-day average of 16.23M — lighter than usual.
- Price is -3.3% vs its 50-day average ($0.45) and -5.0% vs its 200-day average ($0.46).
- 52-week range $0.16–$2.75; today's close sits at 11% of that range, 84.1% below the 52-week high.
MGRX latest news & SEC filings
Every SEC filing by or about MGRX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Oct 9, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Cohen Jacob D. & Tiger Cub Trust gifted 500,000 shares on Sep 30, 2025
- Cohen Jacob D. & Tiger Cub Trust gifted 500,000 shares on Sep 30, 2025; now holds 1,305,000
- Cohen Jacob D. & Tiger Cub Trust received an award of 2,000,000 shares on Jul 28, 2026; now holds 2,000,000
- Cohen Jacob D. & Tiger Cub Trust gifted 2,000,000 shares on Aug 11, 2026
- Cohen Jacob D. & Tiger Cub Trust gifted 2,000,000 shares on Aug 11, 2026; now holds 3,305,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Johnston Eugene M received an award of 100,000 shares on Jul 28, 2026; now holds 220,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hamilton Alex P. received an award of 100,000 shares on Jul 28, 2026; now holds 101,667
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 6, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $68.76K (prior year $168.11K) (-59.1% vs Jun 30, 2025)
- Net income: -$1.31M (prior year -$5.42M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.09 (prior year -$0.57) (loss narrowed vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade MGRX
- Last results release: Aug 15, 2024 (8-K Item 2.02). Previous ones: Oct 19, 2023. Based on that rhythm, the next report is likely around Nov 14, 2024 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 6.37% (largest 17.4%). That is a volatile stock.
- Liquidity: about 702.96K shares (≈$225.65K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.32 vs a range of $0.16–$2.75 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:15 on Oct 16, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: Eugene M Johnston sold 3,333 shares on Dec 15, 2025.
- Latest filings: 8-K Oct 9, 2026; 8-K Oct 1, 2026; 8-K Aug 21, 2026.
- Share count: 21.57M shares outstanding (Aug 13, 2026), +104.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Misc Health & Allied Services, NEC.
MGRX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.34 | 0.36 | 0.32 | 0.32 | 663.70K |
| Oct 14, 2026 | 0.38 | 0.38 | 0.31 | 0.33 | 676.30K |
| Oct 13, 2026 | 0.38 | 0.39 | 0.37 | 0.37 | 299.20K |
| Oct 12, 2026 | 0.42 | 0.42 | 0.38 | 0.38 | 449.30K |
| Oct 9, 2026 | 0.44 | 0.44 | 0.41 | 0.42 | 431.70K |
| Oct 8, 2026 | 0.44 | 0.46 | 0.42 | 0.43 | 583.80K |
| Oct 7, 2026 | 0.43 | 0.48 | 0.43 | 0.44 | 646.10K |
| Oct 6, 2026 | 0.42 | 0.46 | 0.41 | 0.45 | 831.70K |
| Oct 5, 2026 | 0.43 | 0.44 | 0.41 | 0.42 | 576.70K |
| Oct 2, 2026 | 0.43 | 0.44 | 0.43 | 0.44 | 876.20K |
| Oct 1, 2026 | 0.43 | 0.52 | 0.43 | 0.48 | 2.13M |
| Sep 30, 2026 | 0.43 | 0.44 | 0.43 | 0.43 | 204.30K |
| Sep 29, 2026 | 0.39 | 0.46 | 0.38 | 0.44 | 1.14M |
| Sep 28, 2026 | 0.45 | 0.46 | 0.37 | 0.38 | 1.00M |
| Sep 25, 2026 | 0.45 | 0.48 | 0.45 | 0.47 | 83.20K |
| Sep 24, 2026 | 0.44 | 0.48 | 0.44 | 0.46 | 557.60K |
| Sep 23, 2026 | 0.43 | 0.46 | 0.41 | 0.45 | 407.70K |
| Sep 22, 2026 | 0.45 | 0.46 | 0.41 | 0.43 | 472.70K |
| Sep 21, 2026 | 0.47 | 0.48 | 0.44 | 0.45 | 435.60K |
| Sep 18, 2026 | 0.45 | 0.48 | 0.40 | 0.48 | 1.59M |
About Mangoceuticals
Mangoceuticals (MGRX) is listed on the Nasdaq and classified by the SEC under “Services-Misc Health & Allied Services, NEC”. Its business address is in DALLAS, TX. State of incorporation: TX. Fiscal year ends December 31. SEC CIK 1938046.
MGRX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jacob D. Cohen | Chief Executive Officer | Mar 20, 2026 |
| Alex P. Hamilton | Director | Nov 26, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jacob D. Cohen | Chief Executive Officer | Mar 20, 2026 |
| Eugene M Johnston | CFO | Dec 17, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 15, 2025 | Eugene M Johnston | Sale | 3,333 | $1.17 |
| Dec 9, 2025 | Eugene M Johnston | Sale | 5,000 | $1.20 |
| Dec 5, 2025 | Eugene M Johnston | Sale | 10,000 | $1.13 |
| Nov 19, 2025 | Alex P. Hamilton | Sale | 125,000 | $1.22 |
MGRX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $456.02K | $-20.64M | -2.17 | $-5.85M |
| Dec 31, 2024 | $615.87K | $-8.71M | -4.80 | $-4.86M |
| Dec 31, 2023 | $731.49K | $-9.21M | -8.58 | $-7.00M |
| Dec 31, 2022 | $8.94K | $-2.00M | -0.19 | $-1.35M |
Latest balance sheet: total assets $14.17M, total liabilities $1.65M, cash $228.69K (as of Jun 30, 2026).
MGRX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 15, 2024 | 8-K Item 2.02 (results) | — |
| Oct 19, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Misc Health & Allied Services, NEC
Davita (DVA)Sotera Health (SHC)Fresenius Medical Care AG (FMS)Progyny (PGNY)agilon health (AGL)Viemed Healthcare (VMD)NewGenIvf (NIVF)Park Dental Partners (PARK)Cryo Cell International (CCEL)BioRestorative Therapies (BRTX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MGRX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.